International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal,
publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both
education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the
following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact
innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance
and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal
radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying
cancer and normal tissue radiation response.
The Red Journal's sister publications are http://www.practicalradonc.org/Practical
Radiation Oncology and http://www.advancesradonc.org/Advances in Radiation Oncology.
https://www.redjournal.org/pb/assets/raw/Health Advance/journals/rob/Scope_(4.26.18).pdfLearn more about which
types of papers these journals typically accept.
Disclaimer No responsibility is assumed by the Publisher
or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged
libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any
use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical
sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is
expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the
quality or value of such product or of the claims made of it by its manufacturer.
https://www.mea.elsevierhealth.com/international-journal-of-radiation-oncology-8226-biology-8226-physics-03603016.html109589International Journal of Radiation Oncology • Biology • Physicshttps://www.mea.elsevierhealth.com/media/catalog/product/0/3/03603016_21.jpg00USDOutOfStock <IT>International Journal of Radiation Oncology • Biology • Physics (IJROBP)</IT>, known in the field as the Red Journal,
publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both
education and health policy as it relates to the field.
<P>
This journal has a particular interest in original contributions of the
following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact
innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance
and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal
radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying
cancer and normal tissue radiation response.
<P>
The Red Journal's sister publications are <URL><HREF>http://www.practicalradonc.org/</HREF><HTXT>Practical
Radiation Oncology</HTXT></URL> and <URL><HREF>http://www.advancesradonc.org/</HREF><HTXT>Advances in Radiation Oncology</HTXT></URL>.
<URL><HREF>https://www.redjournal.org/pb/assets/raw/Health Advance/journals/rob/Scope_(4.26.18).pdf</HREF><HTXT>Learn more about which
types of papers these journals typically accept.</HTXT></URL>
<P><B>Disclaimer</B><BR>No responsibility is assumed by the Publisher
or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged
libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any
use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical
sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is
expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the
quality or value of such product or of the claims made of it by its manufacturer.
USD000360-3016JOURNALELSEVIERIN STOCK0360-3016Volumes 103-105journalsJournalsNoNoNoNoPlease SelectPlease SelectPlease Select